Premium
Ketamine reduces suicidal ideation in trial with midazolam control
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30304
Subject(s) - ketamine , midazolam , medicine , suicidal ideation , anesthesia , depression (economics) , clinical trial , emergency medicine , poison control , suicide prevention , sedation , economics , macroeconomics
A single infusion of ketamine resulted in a greater reduction in suicidal thoughts in comparison with midazolam among patients with depression, with clinical improvement sustained for up to six weeks, a new study has found. Side effects from ketamine were mild to moderate and usually lasted no more than a few hours after infusion.